SlideShare a Scribd company logo
1 of 22
ADULT HEALTH NURSING
GBSN,SEM-IV
FACULTY: MR.RAFIQUE SYIAL
PRASENTED BY: MUHAMMAD RAEES
Parkinson’s disease
Objectives
 At the end of this presentation the students
will be able to learn about:
 Definition of Parkinson's disease.
 Signs and sym of Parkinson's disease.
 Causes of Parkinson's disease.
 Pathophysiology of Parkinson's disease.
 Diadnose of Parkinson's disease.
 Treatment of Parkinson's disease.
 Nursing management of Parkinson's disease.
Definition
 Parkinson's disease is a progressive disorder
of the nervous system that affects
movement. It develops gradually, sometimes
starting with a barely noticeable tremor in
just one hand. But while a tremor may be the
most well-known sign of Parkinson's disease,
the disorder also commonly causes stiffness
or slowing of movement.
Signs and symptoms
 Tremor.
 Slowed movement (bradykinesia)
 Rigid muscles.
 Impaired posture and balance.
 Loss of automatic movements.
 Speech changes.
 Writing changes.
Causes
 The cause of Parkinson's disease is unknown,
but several factors appear to play a role,
including:
 Your genes. Researchers have identified
specific genetic mutations that can cause
Parkinson's disease, but these are uncommon
except in rare cases with many family
members affected by Parkinson's disease.
Causes
 Environmental triggers. Exposure to certain
toxins or environmental factors may increase the
risk of later Parkinson's disease, but the risk is
relatively small.
 The presence of Lewy bodies. Clumps of
specific substances within brain cells are
microscopic markers of Parkinson's disease.
These are called Lewy bodies, and researchers
believe these Lewy bodies hold an important
clue to the cause of Parkinson's disease.
Risk factors
 Age. People usually develop the disease
around age 60 or older.
 Heredity. Having a close relative with
Parkinson's disease increases the chances
that you'll develop the disease.
 Sex. Men are more likely to develop
Parkinson's disease than are women
 Exposure to toxins.
Additional problems
 Thinking difficulties.
 Depression and emotional changes.
 Swallowing problems.
 Sleep problems and sleep disorders.
 Blood pressure changes.
 Smell dysfunction
 Fatigue.
Pathophysiology
 Parkinson’s disease is primarily associated with the
gradual loss of cells in the substantia nigra of the
brain.This area is responsible for the production of
dopamine. Dopamine is a chemical messenger that
transmits signals between two regions of the brain
to coordinate activity. For example, it connects the
substantia nigra and the corpus striatum to regulate
muscle activity. If there is deficiency of dopamine in
the striatum the nerve cells in this region “fire” out of
control.This leaves the individual unable to direct or
control movements.
Pathophysiology
 .This leads to the initial symptoms of
Parkinson’s disease. As the nervous system
degenerate as well causing a more profound
movement disorder
Diagnosis
 No tests can conclusively show that you
have Parkinson's disease.Your doctor will
base a diagnosis on your symptoms,
medical history and a detailed physical
examination.
Diagnosis
 The finding of Lewy bodies in the midbrain
on autopsy is usually considered final proof
that the person had PD.
 People may be given levodopa, with any
resulting improvement in motor impairment
helping to confirm the PD diagnosis
Treatment
 Parkinson's disease can't be cured, but
medications can help control your symptoms,
often dramatically. In some later cases,
surgery may be advised
 Medications
 Medications may help you manage problems
with walking, movement and tremor.These
medications increase or substitute for
dopamine, a specific signaling chemical
(neurotransmitter) in your brain.
Treatment
 Carbidopa-levodopa.
 Carbidopa-levodopa infusion.
 Dopamine agonists.
 MAO-B inhibitors.These medications include
selegiline (Eldepryl, Zelapar) and rasagiline
(Azilect).They help prevent the breakdown of
brain dopamine by inhibiting the brain enzyme
monoamine oxidase B (MAO-B).This enzyme
metabolizes brain dopamine.
 Anticholinergics.
Surgical procedures
 Deep brain stimulation. In deep brain
stimulation (DBS), surgeons implant
electrodes into a specific part of your brain.
The electrodes are connected to a generator
implanted in your chest near your collarbone
that sends electrical pulses to your brain and
may reduce your Parkinson's disease
symptoms.
Nursing Interventions
 Assess neurological status.
 Assess ability to swallow and chew.
 Provide high-calorie, high-protien, high-fiber
soft diet with small, frequent feedings.
 Increase fluid intake to 2000 mL/day.
 Monitor for constipation.
 Promote independence along with safety
measures
Nursing Interventions
 Administer antiparkinsonian medications to
increase the level of dopamine in the CNS.
 Instruct the client to avoid foods high in
vitamin B6 because they block the effects of
antiparkinsonian medications.
References
 Suchowersky O, et al. (2006). Practice
parameter: Neuroprotective strategies and
alternative therapies for Parkinson disease (an
evidence-based review).
 http://www.neurology.org/content/66/7/968.f
ull.

More Related Content

What's hot (20)

Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
 
Parkinson's Disease (PD)
Parkinson's Disease (PD)Parkinson's Disease (PD)
Parkinson's Disease (PD)
 
Parkinson's Disease - Neurology
Parkinson's Disease - NeurologyParkinson's Disease - Neurology
Parkinson's Disease - Neurology
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n management
 
PARKINSON'S DISEASE Presentation by Rajee
PARKINSON'S DISEASE  Presentation by RajeePARKINSON'S DISEASE  Presentation by Rajee
PARKINSON'S DISEASE Presentation by Rajee
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
 
Parkinson diseases
Parkinson diseasesParkinson diseases
Parkinson diseases
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
Parkinson disease
Parkinson disease Parkinson disease
Parkinson disease
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
 
PARKINSON’S DISEASE
PARKINSON’S DISEASEPARKINSON’S DISEASE
PARKINSON’S DISEASE
 
Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Parkinson's
Parkinson'sParkinson's
Parkinson's
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Parkinson's disease
 Parkinson's disease Parkinson's disease
Parkinson's disease
 
PARKINSON'S DISEASE
PARKINSON'S DISEASEPARKINSON'S DISEASE
PARKINSON'S DISEASE
 

Similar to Parkinson's disease by waheed javed

pksonsds-180320161607.pdf
pksonsds-180320161607.pdfpksonsds-180320161607.pdf
pksonsds-180320161607.pdfNatinderDhillon
 
Parkinson's manasi india 17
Parkinson's  manasi india 17Parkinson's  manasi india 17
Parkinson's manasi india 17Manasi Chavan
 
Parkinson' disease
Parkinson' diseaseParkinson' disease
Parkinson' diseasealiciadiez
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Soujanya Pharm.D
 
TY BSc PAPER -5 Drugs & Dyes , Unit-2 Chapter : Anti-Parkinsonism drugs
TY BSc  PAPER -5  Drugs & Dyes , Unit-2 Chapter :  Anti-Parkinsonism  drugs TY BSc  PAPER -5  Drugs & Dyes , Unit-2 Chapter :  Anti-Parkinsonism  drugs
TY BSc PAPER -5 Drugs & Dyes , Unit-2 Chapter : Anti-Parkinsonism drugs pravin bendle
 
Parkinson's disease and treatment
Parkinson's disease and treatmentParkinson's disease and treatment
Parkinson's disease and treatmentA M O L D E O R E
 
Doctors for Parkinson's Disease near New Delhi || 8010931122
Doctors for Parkinson's Disease near New Delhi || 8010931122Doctors for Parkinson's Disease near New Delhi || 8010931122
Doctors for Parkinson's Disease near New Delhi || 8010931122Dr. Monga Medi Clinic
 
Parkinson's disease Seminar Presentation
Parkinson's disease Seminar PresentationParkinson's disease Seminar Presentation
Parkinson's disease Seminar Presentationpradeepmk8
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.DDr.Sohel Memon
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s diseasevjcummins
 
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdfPARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdfwajidullah9551
 

Similar to Parkinson's disease by waheed javed (20)

Prakash park
Prakash parkPrakash park
Prakash park
 
Anti parkinsonian
Anti parkinsonianAnti parkinsonian
Anti parkinsonian
 
pksonsds-180320161607.pdf
pksonsds-180320161607.pdfpksonsds-180320161607.pdf
pksonsds-180320161607.pdf
 
PARKINSON'S DISEASE.pptx
PARKINSON'S DISEASE.pptxPARKINSON'S DISEASE.pptx
PARKINSON'S DISEASE.pptx
 
Parkinson's manasi india 17
Parkinson's  manasi india 17Parkinson's  manasi india 17
Parkinson's manasi india 17
 
Parkinson' disease
Parkinson' diseaseParkinson' disease
Parkinson' disease
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
parkinsons disease
parkinsons diseaseparkinsons disease
parkinsons disease
 
TY BSc PAPER -5 Drugs & Dyes , Unit-2 Chapter : Anti-Parkinsonism drugs
TY BSc  PAPER -5  Drugs & Dyes , Unit-2 Chapter :  Anti-Parkinsonism  drugs TY BSc  PAPER -5  Drugs & Dyes , Unit-2 Chapter :  Anti-Parkinsonism  drugs
TY BSc PAPER -5 Drugs & Dyes , Unit-2 Chapter : Anti-Parkinsonism drugs
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinson's disease and treatment
Parkinson's disease and treatmentParkinson's disease and treatment
Parkinson's disease and treatment
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
 
Doctors for Parkinson's Disease near New Delhi || 8010931122
Doctors for Parkinson's Disease near New Delhi || 8010931122Doctors for Parkinson's Disease near New Delhi || 8010931122
Doctors for Parkinson's Disease near New Delhi || 8010931122
 
Parkinson's disease Seminar Presentation
Parkinson's disease Seminar PresentationParkinson's disease Seminar Presentation
Parkinson's disease Seminar Presentation
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
 
Parkinsons disease
Parkinsons disease Parkinsons disease
Parkinsons disease
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Neuro parkinsonism
Neuro parkinsonismNeuro parkinsonism
Neuro parkinsonism
 
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdfPARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
PARKINSON'S DISEASE And pathophysiology .pdf by SMH.pdf
 

More from Waheed javed, Student at INDUS COLLEGE OF NURSING

More from Waheed javed, Student at INDUS COLLEGE OF NURSING (16)

Respiratory system examination
Respiratory system examinationRespiratory system examination
Respiratory system examination
 
cardiac assessment
cardiac assessment  cardiac assessment
cardiac assessment
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Brain abscess by waheed
Brain abscess by waheedBrain abscess by waheed
Brain abscess by waheed
 
polycythemia by waheed
polycythemia by waheedpolycythemia by waheed
polycythemia by waheed
 
Protein by waheed
Protein by waheedProtein by waheed
Protein by waheed
 
Urinary calculi by waheed
Urinary calculi by waheedUrinary calculi by waheed
Urinary calculi by waheed
 
renal abscess by waheed
renal abscess by waheedrenal abscess by waheed
renal abscess by waheed
 
Sickle cell anemia by waheed
Sickle cell anemia by waheedSickle cell anemia by waheed
Sickle cell anemia by waheed
 
Leukemia by waheed javed
Leukemia by waheed javedLeukemia by waheed javed
Leukemia by waheed javed
 
Liver cancer.waheed
Liver cancer.waheedLiver cancer.waheed
Liver cancer.waheed
 
Pancreatic pseudocyst by waheed
Pancreatic pseudocyst by waheedPancreatic pseudocyst by waheed
Pancreatic pseudocyst by waheed
 
Glumerulonephritis by waheed
Glumerulonephritis by waheedGlumerulonephritis by waheed
Glumerulonephritis by waheed
 
Gallblader carcinoma.waheed
Gallblader carcinoma.waheedGallblader carcinoma.waheed
Gallblader carcinoma.waheed
 
School uniform
School uniformSchool uniform
School uniform
 
continue assessment test.waheed
continue assessment test.waheedcontinue assessment test.waheed
continue assessment test.waheed
 

Recently uploaded

How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Science lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonScience lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonJericReyAuditor
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 

Recently uploaded (20)

How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Science lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonScience lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lesson
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 

Parkinson's disease by waheed javed

  • 1. ADULT HEALTH NURSING GBSN,SEM-IV FACULTY: MR.RAFIQUE SYIAL PRASENTED BY: MUHAMMAD RAEES Parkinson’s disease
  • 2. Objectives  At the end of this presentation the students will be able to learn about:  Definition of Parkinson's disease.  Signs and sym of Parkinson's disease.  Causes of Parkinson's disease.  Pathophysiology of Parkinson's disease.  Diadnose of Parkinson's disease.  Treatment of Parkinson's disease.  Nursing management of Parkinson's disease.
  • 3. Definition  Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand. But while a tremor may be the most well-known sign of Parkinson's disease, the disorder also commonly causes stiffness or slowing of movement.
  • 4.
  • 5. Signs and symptoms  Tremor.  Slowed movement (bradykinesia)  Rigid muscles.  Impaired posture and balance.  Loss of automatic movements.  Speech changes.  Writing changes.
  • 6.
  • 7. Causes  The cause of Parkinson's disease is unknown, but several factors appear to play a role, including:  Your genes. Researchers have identified specific genetic mutations that can cause Parkinson's disease, but these are uncommon except in rare cases with many family members affected by Parkinson's disease.
  • 8. Causes  Environmental triggers. Exposure to certain toxins or environmental factors may increase the risk of later Parkinson's disease, but the risk is relatively small.  The presence of Lewy bodies. Clumps of specific substances within brain cells are microscopic markers of Parkinson's disease. These are called Lewy bodies, and researchers believe these Lewy bodies hold an important clue to the cause of Parkinson's disease.
  • 9. Risk factors  Age. People usually develop the disease around age 60 or older.  Heredity. Having a close relative with Parkinson's disease increases the chances that you'll develop the disease.  Sex. Men are more likely to develop Parkinson's disease than are women  Exposure to toxins.
  • 10. Additional problems  Thinking difficulties.  Depression and emotional changes.  Swallowing problems.  Sleep problems and sleep disorders.  Blood pressure changes.  Smell dysfunction  Fatigue.
  • 11. Pathophysiology  Parkinson’s disease is primarily associated with the gradual loss of cells in the substantia nigra of the brain.This area is responsible for the production of dopamine. Dopamine is a chemical messenger that transmits signals between two regions of the brain to coordinate activity. For example, it connects the substantia nigra and the corpus striatum to regulate muscle activity. If there is deficiency of dopamine in the striatum the nerve cells in this region “fire” out of control.This leaves the individual unable to direct or control movements.
  • 12. Pathophysiology  .This leads to the initial symptoms of Parkinson’s disease. As the nervous system degenerate as well causing a more profound movement disorder
  • 13.
  • 14. Diagnosis  No tests can conclusively show that you have Parkinson's disease.Your doctor will base a diagnosis on your symptoms, medical history and a detailed physical examination.
  • 15. Diagnosis  The finding of Lewy bodies in the midbrain on autopsy is usually considered final proof that the person had PD.  People may be given levodopa, with any resulting improvement in motor impairment helping to confirm the PD diagnosis
  • 16. Treatment  Parkinson's disease can't be cured, but medications can help control your symptoms, often dramatically. In some later cases, surgery may be advised  Medications  Medications may help you manage problems with walking, movement and tremor.These medications increase or substitute for dopamine, a specific signaling chemical (neurotransmitter) in your brain.
  • 17. Treatment  Carbidopa-levodopa.  Carbidopa-levodopa infusion.  Dopamine agonists.  MAO-B inhibitors.These medications include selegiline (Eldepryl, Zelapar) and rasagiline (Azilect).They help prevent the breakdown of brain dopamine by inhibiting the brain enzyme monoamine oxidase B (MAO-B).This enzyme metabolizes brain dopamine.  Anticholinergics.
  • 18. Surgical procedures  Deep brain stimulation. In deep brain stimulation (DBS), surgeons implant electrodes into a specific part of your brain. The electrodes are connected to a generator implanted in your chest near your collarbone that sends electrical pulses to your brain and may reduce your Parkinson's disease symptoms.
  • 19.
  • 20. Nursing Interventions  Assess neurological status.  Assess ability to swallow and chew.  Provide high-calorie, high-protien, high-fiber soft diet with small, frequent feedings.  Increase fluid intake to 2000 mL/day.  Monitor for constipation.  Promote independence along with safety measures
  • 21. Nursing Interventions  Administer antiparkinsonian medications to increase the level of dopamine in the CNS.  Instruct the client to avoid foods high in vitamin B6 because they block the effects of antiparkinsonian medications.
  • 22. References  Suchowersky O, et al. (2006). Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review).  http://www.neurology.org/content/66/7/968.f ull.